Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Multicriteria plan optimization in the hands of physicians: a pilot study in prostate cancer and brain tumors

Fig. 4

a Normalized dose differences of prostate plans of performed t-tests; we also computed the non-parametric Wilcoxon signed rank p-statistics since some of the difference data do not pass the Lilliefors normality test (due to the outliers). Those p-values lead to the same conclusions as the p-values from the t-test. Starting with PTV D95, they are 0.08, 0.70, 0.03, 0.004, 0.04, 0.43, and 0.92. b Normalized dose differences of brain tumor plans of performed t-tests; p-values of the Wilcoxon signed rank test, starting at PTV D95, are 0.97, 0.05, 0.23, 0.20, 0.019; remarks: CTV refers to 11 CTVs and one GTV contour; brainstem statistics based on 11 contours

Back to article page